Cysteine is one of the least abundant but most conserved amino acid residues in proteins, playing a role in their structure, metal binding, catalysis, and redox chemistry. Thiols present in cysteines can be modified by post-translational modifications like sulfenylation, acylation, or glutathionylation, regulating protein activity and function and serving as signals. Their modification depends on their position in the structure, surrounding amino acids, solvent accessibility, pH, etc. The most studied modifications are the redox modifications by reactive oxygen, nitrogen, and sulfur species, leading to reversible changes that serve as cell signals or irreversible changes indicating oxidative stress and cell damage. Selected antioxidants undergoing reversible oxidative modifications like peroxiredoxin-thioredoxin system are involved in a redox-relay signaling that can propagate to target proteins. Cysteine thiols can also be modified by acyl moieties' addition (derived from lipid metabolism), resulting in protein functional modification or changes in protein anchoring in the membrane. In this review, we update the current knowledge on cysteine modifications and their consequences in pancreatic β-cells. Because β-cells exhibit well-balanced redox homeostasis, the redox modifications of cysteines here serve primarily for signaling purposes. Similarly, lipid metabolism provides regulatory intermediates that have been shown to be necessary in addition to redox modifications for proper β-cell function and, in particular, for efficient insulin secretion. On the contrary, the excess of reactive oxygen, nitrogen, and sulfur species and the imbalance of lipids under pathological conditions cause irreversible changes and contribute to oxidative stress leading to cell failure and the development of type 2 diabetes.

Laboratory of Pancreatic Islet Research Institute of Physiology Czech Academy of Sciences Prague Czechia

Erratum v

Front Endocrinol (Lausanne). 2024 Mar 20;15:1399741. doi: 10.3389/fendo.2024.1399741. PubMed

Zobrazit více v PubMed

Poole LB. The basics of thiols and cysteines in redox biology and chemistry. Free Radic Biol Med (2015) 80:148–57. doi: 10.1016/j.freeradbiomed.2014.11.013 PubMed DOI PMC

Marino SM, Gladyshev VN. Cysteine function governs its conservation and degeneration and restricts its utilization on protein surfaces. J Mol Biol (2010) 404:902–16. doi: 10.1016/j.jmb.2010.09.027 PubMed DOI PMC

Flohé L. The fairytale of the GSSG/GSH redox potential. Biochim Biophys Acta (2013) 1830:3139–42. doi: 10.1016/j.bbagen.2012.10.020 PubMed DOI

Winterbourn CC. Reconciling the chemistry and biology of reactive oxygen species. Nat Chem Biol (2008) 4:278–86. doi: 10.1038/nchembio.85 PubMed DOI

Nagy P. Kinetics and mechanisms of thiol-disulfide exchange covering direct substitution and thiol oxidation-mediated pathways. Antioxid Redox Signal (2013) 18:1623–41. doi: 10.1089/ars.2012.4973 PubMed DOI PMC

Winterbourn CC, Hampton MB. Thiol chemistry and specificity in redox signaling. Free Radical Biol Med (2008) 45:549–61. doi: 10.1016/j.freeradbiomed.2008.05.004 PubMed DOI

Jensen KS, Hansen RE, Winther JR. Kinetic and thermodynamic aspects of cellular thiol-disulfide redox regulation. Antioxid Redox Signal (2009) 11:1047–58. doi: 10.1089/ars.2008.2297 PubMed DOI

Jones DP. Radical-free biology of oxidative stress. Am J Physiol Cell Physiol (2008) 295:C849–68. doi: 10.1152/ajpcell.00283.2008 PubMed DOI PMC

Kemp M, Go YM, Jones DP. Nonequilibrium thermodynamics of thiol/disulfide redox systems: a perspective on redox systems biology. Free Radic Biol Med (2008) 44:921–37. doi: 10.1016/j.freeradbiomed.2007.11.008 PubMed DOI PMC

Chung HS, Wang SB, Venkatraman V, Murray CI, Van Eyk JE. Cysteine oxidative posttranslational modifications: emerging regulation in the cardiovascular system. Circ Res (2013) 112:382–92. doi: 10.1161/CIRCRESAHA.112.268680 PubMed DOI PMC

Peskin AV, Dickerhof N, Poynton RA, Paton LN, Pace PE, Hampton MB, et al. . Hyperoxidation of peroxiredoxins 2 and 3: rate constants for the reactions of the sulfenic acid of the peroxidatic cysteine. J Biol Chem (2013) 288:14170–7. doi: 10.1074/jbc.M113.460881 PubMed DOI PMC

Poole LB, Karplus PA, Claiborne A. Protein sulfenic acids in redox signaling. Annu Rev Pharmacol Toxicol (2004) 44:325–47. doi: 10.1146/annurev.pharmtox.44.101802.121735 PubMed DOI

Kabil O, Banerjee R. Enzymology of H2S biogenesis, decay and signaling. Antioxid Redox Signal (2014) 20:770–82. doi: 10.1089/ars.2013.5339 PubMed DOI PMC

Smith BC, Marletta MA. Mechanisms of s-nitrosothiol formation and selectivity in nitric oxide signaling. Curr Opin Chem Biol (2012) 16:498–506. doi: 10.1016/j.cbpa.2012.10.016 PubMed DOI PMC

Luc R, Vergely C. Forgotten radicals in biology. Int J BioMed Sci (2008) 4:255–9. PubMed PMC

Plecitá-Hlavatá L, Ježek P. Integration of superoxide formation and cristae morphology for mitochondrial redox signaling. Int J Biochem Cell Biol (2016) 80:31–50. doi: 10.1016/j.biocel.2016.09.010 PubMed DOI

Jena AB, Samal RR, Bhol NK, Duttaroy AK. Cellular red-ox system in health and disease: the latest update. Biomed pharmacother = Biomed pharmacotherapie (2023) 162:114606. doi: 10.1016/j.biopha.2023.114606 PubMed DOI

Rashdan NA, Shrestha B, Pattillo CB. S-glutathionylation, friend or foe in cardiovascular health and disease. Redox Biol (2020) 37:101693. doi: 10.1016/j.redox.2020.101693 PubMed DOI PMC

Burns M, Rizvi SHM, Tsukahara Y, Pimentel DR, Luptak I, Hamburg NM, et al. . Role of glutaredoxin-1 and glutathionylation in cardiovascular diseases. Int J Mol Sci (2020) 21:6803. doi: 10.3390/ijms21186803 PubMed DOI PMC

Chia SB, Elko EA, Aboushousha R, Manuel AM, van de Wetering C, Druso JE, et al. . Dysregulation of the glutaredoxin/S-glutathionylation redox axis in lung diseases. Am J Physiol Cell Physiol (2020) 318:C304–c327. doi: 10.1152/ajpcell.00410.2019 PubMed DOI PMC

Mullen L, Mengozzi M, Hanschmann EM, Alberts B, Ghezzi P. How the redox state regulates immunity. Free Radic Biol Med (2020) 157:3–14. doi: 10.1016/j.freeradbiomed.2019.12.022 PubMed DOI

Anathy V, Roberson EC, Guala AS, Godburn KE, Budd RC, Janssen-Heininger YM. Redox-based regulation of apoptosis: s-glutathionylation as a regulatory mechanism to control cell death. Antioxid Redox Signal (2012) 16:496–505. doi: 10.1089/ars.2011.4281 PubMed DOI PMC

Hayes JD, Dinkova-Kostova AT, Tew KD. Oxidative stress in cancer. Cancer Cell (2020) 38:167–97. doi: 10.1016/j.ccell.2020.06.001 PubMed DOI PMC

Xiong Y, Uys JD, Tew KD, Townsend DM. S-glutathionylation: from molecular mechanisms to health outcomes. Antioxid Redox Signal (2011) 15:233–70. doi: 10.1089/ars.2010.3540 PubMed DOI PMC

Matsui R, Ferran B, Oh A, Croteau D, Shao D, Han J, et al. . Redox regulation via glutaredoxin-1 and protein s-glutathionylation. Antioxid Redox Signal (2020) 32:677–700. doi: 10.1089/ars.2019.7963 PubMed DOI PMC

Chen JJ, Fan Y, Boehning D. Regulation of dynamic protein s-acylation. Front Mol Biosci (2021) 8:656440. doi: 10.3389/fmolb.2021.656440 PubMed DOI PMC

Montigny C, Decottignies P, Le Maréchal P, Capy P, Bublitz M, Olesen C, et al. . S-palmitoylation and s-oleoylation of rabbit and pig sarcolipin. J Biol Chem (2014) 289:33850–61. doi: 10.1074/jbc.M114.590307 PubMed DOI PMC

Thinon E, Percher A, Hang HC. Bioorthogonal chemical reporters for monitoring unsaturated fatty-acylated proteins. Chembiochem Eur J Chem Biol (2016) 17:1800–3. doi: 10.1002/cbic.201600213 PubMed DOI PMC

Liang X, Nazarian A, Erdjument-Bromage H, Bornmann W, Tempst P, Resh MD. Heterogeneous fatty acylation of src family kinases with polyunsaturated fatty acids regulates raft localization and signal transduction. J Biol Chem (2001) 276:30987–94. doi: 10.1074/jbc.M104018200 PubMed DOI

Senyilmaz D, Virtue S, Xu X, Tan CY, Griffin JL, Miller AK, et al. . Regulation of mitochondrial morphology and function by stearoylation of TFR1. Nature (2015) 525:124–8. doi: 10.1038/nature14601 PubMed DOI PMC

Muszbek L, Haramura G, Cluette-Brown JE, Van Cott EM, Laposata M. The pool of fatty acids covalently bound to platelet proteins by thioester linkages can be altered by exogenously supplied fatty acids. Lipids (1999) 34 Suppl:S331–7. doi: 10.1007/BF02562334 PubMed DOI

Brett K, Kordyukova LV, Serebryakova MV, Mintaev RR, Alexeevski AV, Veit M. Site-specific s-acylation of influenza virus hemagglutinin: the location of the acylation site relative to the membrane border is the decisive factor for attachment of stearate. J Biol Chem (2014) 289:34978–89. doi: 10.1074/jbc.M114.586180 PubMed DOI PMC

Tsuchiya Y, Peak-Chew SY, Newell C, Miller-Aidoo S, Mangal S, Zhyvoloup A, et al. . Protein CoAlation: a redox-regulated protein modification by coenzyme a in mammalian cells. Biochem J (2017) 474:2489–508. doi: 10.1042/BCJ20170129 PubMed DOI PMC

Leonardi R, Zhang YM, Rock CO, Jackowski S, Coenzyme A. Back in action. Prog Lipid Res (2005) 44:125–53. doi: 10.1016/j.plipres.2005.04.001 PubMed DOI

Tossounian MA, Baczynska M, Dalton W, Newell C, Ma Y, Das S, et al. . Profiling the site of protein CoAlation and coenzyme a stabilization interactions. Antioxidants (Basel Switzerland) (2022) 11:1362. doi: 10.3390/antiox11071362 PubMed DOI PMC

Lenzen S, Drinkgern J, Tiedge M. Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radical Biol Med (1996) 20:463–6. doi: 10.1016/0891-5849(96)02051-5 PubMed DOI

Plecita-Hlavata L, Jaburek M, Holendova B, Tauber J, Pavluch V, Berkova Z, et al. . Glucose-stimulated insulin secretion fundamentally requires H2O2 signaling by NADPH oxidase 4. Diabetes (2020) 69:1341–54. doi: 10.2337/db19-1130 PubMed DOI

Benáková Š., Holendová B, Plecitá-Hlavatá L. Redox homeostasis in pancreatic β-cells: from development to failure. Antioxidants (Basel Switzerland) (2021) 10. doi: 10.3390/antiox10040526 PubMed DOI PMC

Mittal M, Gu XQ, Pak O, Pamenter ME, Haag D, Fuchs DB, et al. . Hypoxia induces kv channel current inhibition by increased NADPH oxidase-derived reactive oxygen species. Free Radic Biol Med (2012) 52:1033–42. doi: 10.1016/j.freeradbiomed.2011.12.004 PubMed DOI

Ferdaoussi M, MacDonald PE. Toward connecting metabolism to the exocytotic site. Trends Cell Biol (2017) 27:163–71. doi: 10.1016/j.tcb.2016.10.003 PubMed DOI

Lorenzen I, Eble JA, Hanschmann EM. Thiol switches in membrane proteins - extracellular redox regulation in cell biology. Biol Chem (2020) 402:253–269. doi: 10.1515/hsz-2020-0266 PubMed DOI

Corkey BE, Shirihai O. Metabolic master regulators: sharing information among multiple systems. Trends Endocrinol metabolism: TEM (2012) 23:594–601. doi: 10.1016/j.tem.2012.07.006 PubMed DOI PMC

Scheuner D, Kaufman RJ. The unfolded protein response: a pathway that links insulin demand with beta-cell failure and diabetes. Endocrine Rev (2008) 29:317–33. doi: 10.1210/er.2007-0039 PubMed DOI PMC

Oslowski CM, Hara T, O'Sullivan-Murphy B, Kanekura K, Lu S, Hara M, et al. . Thioredoxin-interacting protein mediates ER stress-induced β cell death through initiation of the inflammasome. Cell Metab (2012) 16:265–73. doi: 10.1016/j.cmet.2012.07.005 PubMed DOI PMC

Sokolova M, Sahraoui A, Høyem M, Øgaard J, Lien E, Aukrust P, et al. . NLRP3 inflammasome mediates oxidative stress-induced pancreatic islet dysfunction. Am J Physiol Endocrinol Metab (2018) 315:E912–e923. doi: 10.1152/ajpendo.00461.2017 PubMed DOI

Xu Z, Lam LS, Lam LH, Chau SF, Ng TB, Au SW. Molecular basis of the redox regulation of SUMO proteases: a protective mechanism of intermolecular disulfide linkage against irreversible sulfhydryl oxidation. FASEB J (2008) 22:127–37. doi: 10.1096/fj.06-7871com PubMed DOI

Casey JR, Grinstein S, Orlowski J. Sensors and regulators of intracellular pH. Nat Rev Mol Cell Biol (2010) 11:50–61. doi: 10.1038/nrm2820 PubMed DOI

Jones DP, Go YM. Redox compartmentalization and cellular stress. Diabetes Obes Metab (2010) 12 Suppl 2:116–25. doi: 10.1111/j.1463-1326.2010.01266.x PubMed DOI PMC

Kirlin WG, Cai J, Thompson SA, Diaz D, Kavanagh TJ, Jones DP. Glutathione redox potential in response to differentiation and enzyme inducers. Free Radic Biol Med (1999) 27:1208–18. doi: 10.1016/S0891-5849(99)00145-8 PubMed DOI

Bakhmutova-Albert EV, Yao H, Denevan DE, Richardson DE. Kinetics and mechanism of peroxymonocarbonate formation. Inorg Chem (2010) 49:11287–96. doi: 10.1021/ic1007389 PubMed DOI

Benham AM, van Lith M, Sitia R, Braakman I. Ero1-PDI interactions, the response to redox flux and the implications for disulfide bond formation in the mammalian endoplasmic reticulum. Philos Trans R Soc Lond B Biol Sci (2013) 368:20110403. doi: 10.1098/rstb.2011.0403 PubMed DOI PMC

Zito E, Melo EP, Yang Y, Wahlander Å., Neubert TA, Ron D. Oxidative protein folding by an endoplasmic reticulum-localized peroxiredoxin. Mol Cell (2010) 40:787–97. doi: 10.1016/j.molcel.2010.11.010 PubMed DOI PMC

Inaba K, Masui S, Iida H, Vavassori S, Sitia R, Suzuki M. Crystal structures of human Ero1α reveal the mechanisms of regulated and targeted oxidation of PDI. EMBO J (2010) 29:3330–43. doi: 10.1038/emboj.2010.222 PubMed DOI PMC

Yoboue ED, Rimessi A, Anelli T, Pinton P, Sitia R. Regulation of calcium fluxes by GPX8, a type-II transmembrane peroxidase enriched at the mitochondria-associated endoplasmic reticulum membrane. Antioxid Redox Signal (2017) 27:583–95. doi: 10.1089/ars.2016.6866 PubMed DOI

Granatiero V, Konrad C, Bredvik K, Manfredi G, Kawamata H. Nrf2 signaling links ER oxidative protein folding and calcium homeostasis in health and disease. Life Sci alliance (2019) 2:e201900563. doi: 10.26508/lsa.201900563 PubMed DOI PMC

Carvalho-Filho MA, Ueno M, Hirabara SM, Seabra AB, Carvalheira JB, de Oliveira MG, et al. . S-nitrosation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/Akt: a novel mechanism of insulin resistance. Diabetes (2005) 54:959–67. doi: 10.2337/diabetes.54.4.959 PubMed DOI

Sugita H, Fujimoto M, Yasukawa T, Shimizu N, Sugita M, Yasuhara S, et al. . Inducible nitric-oxide synthase and NO donor induce insulin receptor substrate-1 degradation in skeletal muscle cells. J Biol Chem (2005) 280:14203–11. doi: 10.1074/jbc.M411226200 PubMed DOI

Pilon G, Charbonneau A, White PJ, Dallaire P, Perreault M, Kapur S, et al. . Endotoxin mediated-iNOS induction causes insulin resistance via ONOO- induced tyrosine nitration of IRS-1 in skeletal muscle. PloS One (2010) 5:e15912. doi: 10.1371/journal.pone.0015912 PubMed DOI PMC

Wang H, Wang AX, Aylor K, Barrett EJ. Nitric oxide directly promotes vascular endothelial insulin transport. Diabetes (2013) 62:4030–42. doi: 10.2337/db13-0627 PubMed DOI PMC

Ropelle ER, Pauli JR, Cintra DE, da Silva AS, De Souza CT, Guadagnini D, et al. . Targeted disruption of inducible nitric oxide synthase protects against aging, s-nitrosation, and insulin resistance in muscle of male mice. Diabetes (2013) 62:466–70. doi: 10.2337/db12-0339 PubMed DOI PMC

Sitar T, Popowicz GM, Siwanowicz I, Huber R, Holak TA. Structural basis for the inhibition of insulin-like growth factors by insulin-like growth factor-binding proteins. Proc Natl Acad Sci U.S.A. (2006) 103:13028–33. doi: 10.1073/pnas.0605652103 PubMed DOI PMC

Goldstein BJ, Mahadev K, Wu X. Redox paradox: insulin action is facilitated by insulin-stimulated reactive oxygen species with multiple potential signaling targets. Diabetes (2005) 54:311–21. doi: 10.2337/diabetes.54.2.311 PubMed DOI PMC

Netto LES, Machado L. Preferential redox regulation of cysteine-based protein tyrosine phosphatases: structural and biochemical diversity. FEBS J (2022) 289:5480–504. doi: 10.1111/febs.16466 PubMed DOI

Groen A, Lemeer S, van der Wijk T, Overvoorde J, Heck AJ, Ostman A, et al. . Differential oxidation of protein-tyrosine phosphatases. J Biol Chem (2005) 280:10298–304. doi: 10.1074/jbc.M412424200 PubMed DOI

Rinna A, Torres M, Forman HJ. Stimulation of the alveolar macrophage respiratory burst by ADP causes selective glutathionylation of protein tyrosine phosphatase 1B. Free Radic Biol Med (2006) 41:86–91. doi: 10.1016/j.freeradbiomed.2006.03.010 PubMed DOI PMC

Chen YY, Chu HM, Pan KT, Teng CH, Wang DL, Wang AH, et al. . Cysteine s-nitrosylation protects protein-tyrosine phosphatase 1B against oxidation-induced permanent inactivation. J Biol Chem (2008) 283:35265–72. doi: 10.1074/jbc.M805287200 PubMed DOI PMC

Sánchez-Gómez FJ, Espinosa-Díez C, Dubey M, Dikshit M, Lamas S. S-glutathionylation: relevance in diabetes and potential role as a biomarker. Biol Chem (2013) 394:1263–80. doi: 10.1515/hsz-2013-0150 PubMed DOI

Corkey BE, Deeney JT, Merrins MJ. What regulates basal insulin secretion and causes hyperinsulinemia? Diabetes (2021) 70:2174–82. doi: 10.2337/dbi21-0009 PubMed DOI PMC

Prescott GR, Gorleku OA, Greaves J, Chamberlain LH. Palmitoylation of the synaptic vesicle fusion machinery. J neurochem (2009) 110:1135–49. doi: 10.1111/j.1471-4159.2009.06205.x PubMed DOI

Cheng H, Straub SG, Sharp GW. Protein acylation in the inhibition of insulin secretion by norepinephrine, somatostatin, galanin, and PGE2. Am J Physiol Endocrinol Metab (2003) 285:E287–94. doi: 10.1152/ajpendo.00535.2002 PubMed DOI

Larsson O, Deeney JT, Branstrom R, Berggren PO, Corkey BE. Activation of the ATP-sensitive k+ channel by long chain acyl-CoA. a role in modulation of pancreatic beta-cell glucose sensitivity. J Biol Chem (1996) 271:10623–6. doi: 10.1074/jbc.271.18.10623 PubMed DOI

Tarasov A, Dusonchet J, Ashcroft F. Metabolic regulation of the pancreatic beta-cell ATP-sensitive k+ channel: a pas de deux. Diabetes (2004) 53 Suppl 3:S113–22. doi: 10.2337/diabetes.53.suppl_3.S113 PubMed DOI

Lorenz MA, El Azzouny MA, Kennedy RT, Burant CF. Metabolome response to glucose in the β-cell line INS-1 832/13. J Biol Chem (2013) 288:10923–35. doi: 10.1074/jbc.M112.414961 PubMed DOI PMC

Qin N, Platano D, Olcese R, Costantin JL, Stefani E, Birnbaumer L. Unique regulatory properties of the type 2a Ca2+ channel beta subunit caused by palmitoylation. Proc Natl Acad Sci U.S.A. (1998) 95:4690–5. doi: 10.1073/pnas.95.8.4690 PubMed DOI PMC

Duncan PJ, Bi D, McClafferty H, Chen L, Tian L, Shipston MJ. S-acylation controls functional coupling of BK channel pore-forming alpha-subunits and beta1-subunits. J Biol Chem (2019) 294:12066–76. doi: 10.1074/jbc.RA119.009065 PubMed DOI PMC

Chamberlain LH, Shipston MJ, Gould GW. Regulatory effects of protein s-acylation on insulin secretion and insulin action. Open Biol (2021) 11:210017. doi: 10.1098/rsob.210017 PubMed DOI PMC

Ciapaite J, Bakker SJ, Diamant M, van Eikenhorst G, Heine RJ, Westerhoff HV, et al. . Metabolic control of mitochondrial properties by adenine nucleotide translocator determines palmitoyl-CoA effects. Implications Mech linking Obes type 2 diabetes FEBS J (2006) 273:5288–302. doi: 10.1111/j.1742-4658.2006.05523.x PubMed DOI

Redox Status as a Key Driver of Healthy Pancreatic Beta-Cells